Zurück zum Inhalt

Onkologie

Transfusionsrisiken und Unabwägbarkeiten

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (öffnet neues Fenster)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Quelle‎: Surgery 2012;152(3):344-54.

Indiziert‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (öffnet neues Fenster)

Perioperative blood transfusions promote pancreas cancer progression. (öffnet neues Fenster)

Benson D, Barnett CC Jr.

Quelle‎: J Surg Res 2011;166(2):275-9.

Indiziert‎: PubMed 20828757

DOI‎: 10.1016/j.jss.2010.05.059

https://www.ncbi.nlm.nih.gov/pubmed/20828757 (öffnet neues Fenster)

Impact of allogeneic and autologous transfusion on immune function in patients with tumors. (öffnet neues Fenster)

Guo JR, Xu F, Jin XJ, Shen HC, Liu Y, Zhang YW, Shao Y.

Quelle‎: Asian Pac J Cancer Prev 2014;15(1):467-74.

Indiziert‎: PubMed 24528076

https://www.ncbi.nlm.nih.gov/pubmed/24528076 (öffnet neues Fenster)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (öffnet neues Fenster)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Quelle‎: Ann Med Surg (Lond) 2016;6:6-11.

Indiziert‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (öffnet neues Fenster)

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. (öffnet neues Fenster)

Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.

Quelle‎: Arch Intern Med 2008;168(21):2377-81.

Indiziert‎: PubMed 19029504

DOI‎: 10.1001/archinte.168.21.2377

https://www.ncbi.nlm.nih.gov/pubmed/19029504 (öffnet neues Fenster)

Perioperative blood transfusion, age at surgery, and prognosis in a database of 526 upper gastrointestinal cancers. (öffnet neues Fenster)

Kosumi K, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H.

Quelle‎: Dig Surg 2015;32(6):445-53.

Indiziert‎: PubMed 26550999

DOI‎: 10.1159/000433609

https://www.ncbi.nlm.nih.gov/pubmed/26550999 (öffnet neues Fenster)

Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. (öffnet neues Fenster)

Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, Zhou Y, Zhou Y, Zhang Y.

Quelle‎: PLoS One 2013;8(5):e64261.

Indiziert‎: PubMed 23741309

DOI‎: 10.1371/journal.pone.0064261

https://www.ncbi.nlm.nih.gov/pubmed/23741309 (öffnet neues Fenster)

Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. (öffnet neues Fenster)

Melis M, McLoughlin JM, Dean EM, Siegel EM, Weber JM, Shah N, Kelley ST, Karl RC.

Quelle‎: J Surg Res 2009;153(1):114-20.

Indiziert‎: PubMed 19201421

DOI‎: 10.1016/j.jss.2008.06.005

https://www.ncbi.nlm.nih.gov/pubmed/19201421 (öffnet neues Fenster)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (öffnet neues Fenster)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Quelle‎: Cancer Treat Rev 2016;46:1-8.

Indiziert‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (öffnet neues Fenster)

Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. (öffnet neues Fenster)

Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch KW, Thasler WE.

Quelle‎: Dis Colon Rectum 2015;58(1):74-82.

Indiziert‎: PubMed 25489697

DOI‎: 10.1097/DCR.0000000000000233

https://www.ncbi.nlm.nih.gov/pubmed/25489697 (öffnet neues Fenster)